With the advancement of the "Belt and Road" national strategy, Chinese equipment "going out" is also accelerating. The advent of this vehicle will help fill the gap in China's high-end heavy mining vehicles participating in the construction of world-class mining projects.
According to statistics, the world-class CR240E has a maximum carrying capacity of 240 tons and a maximum speed of 57km/h. According to the provincial time of 20s, it is suitable for transportation in various mining areas and conditions under complex conditions. The vehicle's vehicle technology is at the leading domestic level. It can compete on the same stage with international mining giant products, anti-rollover/anti-dropping technology in the cab, LNG/diesel dual-fuel engine control technology, brake anti-drag technology and many other mines. A number of breakthroughs have been made in the core technology of the car. According to calculations, only one technology of LNG/diesel engine dual fuel is used. Each vehicle can save more than 1.5 million yuan in fuel cost for a year, which can create considerable economic benefits for users.
It is understood that with the development of the world economy and the upgrading of large-scale mining equipment, the demand for heavy-duty mining electric wheels will increase. The demand for the vehicle in the South American market is relatively strong, only the BHP Chile branch in 2019- In 2025, 90 or more 240-ton or more mining vehicles will need to be purchased. The Erqi Locomotive Company is expected to enter the global market through cooperation with the Chilean BHP project. The advent of this vehicle will help China's CRRC products win the share of the global mining truck market and break the monopoly of the industry. It has also laid a strong foundation for the internationally renowned brands of CRRC.
Influenza Vaccine, Live, Nasal, Freeze-dried Exclusively authorized by the WHO in China
Influenza Vaccine, Live, Nasal, Freeze-dried is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccines (GAP)[1]. Hundreds of millions of doses have been used in the world, and Changchun BCHT Biotechnology Co. has the exclusive right of production and
operation in China.
Intranasal spray administration, no injection and no pain
The vaccine is inoculated by nasal spray, equipped with nasal spray device, and only needs to spray once a year in two nostrils to prevent influenza.
Mucosal immunity + Cellular immunity + Humoral immunity
After influenza virus attacks human body, it widely exists in nasal cavity, respiratory tract and other mucosal parts, as well as in body fluids and cells.
Vaccination of Influenza Vaccine, Live, Nasal, Freeze-dried can quickly stimulate the triple immune response of human body, and carry out defense
against viruses in different parts:
·Intranasal administration can produce mucosal immunity (IgA antibody), which forms the first immune defense line in the nasal cavity.
·Produce humoral immunity (IgG antibody) to remove influenza virus from body fluids.
·Produce cellular immunity (T cells) to remove influenza virus from cells
3+N More extensive protection
The production strains are recommended and supplied by the WHO every year.
The vaccine can not only effectively resist the vaccine strain, but also produce cross immunity to other subtypes of influenza virus.
Produced with SPF embryonated eggs
SPF
The chick embryos for vaccine production comes from SPF (specific pathogen free) chicken flocks, so the risk of exogenous pathogenic microorganism
pollution is excluded.
Free of inactivator, split agent and preservative
Influenza Vaccine Live Manufactured,Influenza Vaccines In Vial,Flu Vaccine In Vial,Influenza Vaccine While Having Flu
Changchun BCHT Biotechnology Co. , https://www.ccbcht.net